FindTrial
Sign In

Study of outcomes after vitamin D supplementation in HIV positive children

Study of Effect of Vitamin D supplementation in Human Immunodeficiency Virus infected children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013290
Enrollment
51
Registered
2018-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- VITAMIN D deficiency

Interventions

Intervention1: VITAMIN D supplementatiom: Vitamin D supplemented in HIV patients with deficeint or insufficient Vitamin D levels. 2,40,000 IU stat on day 1 in form of 4 vitamin D3 sachets containing 6

Sponsors

MOTI LAL NEHRU MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All HIV infected children with parents with 1) Age 18 months-18 years 2) On Highly Active Anti Retroviral Therapy

Exclusion criteria

Exclusion criteria: HIV infected children patients 1) Receiving any form of Vitamin D or Calcium supplementation 2) Having pre-existing tuberculosis or any other opportunistic infection

Design outcomes

Primary

MeasureTime frame
IMMUNITY STATUS wuth CD4 countTimepoint: 4 months—

Secondary

MeasureTime frame
OPPORTUNISTIC INFECTIONSTimepoint: 4 months—

Countries

India

Contacts

Public ContactANUBHA SHRIVASTAVA

MOTI LAL NEHRU MEDICAL COLLEGE, ALLAHABAD

anubhashrivastava@rediffmail.com9236804326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026